[Google Scholar] 55.Pan S., Sun N., Li J., Wang X., Zhao J., Zhang Y., Li J
This article provides a direct comparison between AOD-9604 and tesamorelin
If it continues, GERD can cause scarring and narrowing of the esophagus and increase a persons risk of esophageal cancer.Results show that people taking GLP-1 drugs were 27% more likely to develop GERD and 55% more likely to have GERD complications, when compared to people taking SGLT-2 inhibitors.More than 90% of GERD complications involved Barrett esophagus, in which acid damage changes the tissue lining of the esophagus and increases cancer risk, researchers noted.We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use, researchers wrote.However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity.There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes, researchers wrote
Months 4-6: Total loss typically 20-35 pounds, need for new wardrobe, compliments from Nocatee neighbors and friends, continued progress toward goal
Speak with your healthcare provider about these alternatives to find out if any of these medications are right for you
